Generic donepezil is the 1st-line acetylcholinesterase inhibitor for mild to moderate Alzheimer's disease.  Galantamine or rivastigmine are alternative AChE inhibitors. Rivastigmine is also a treatment option for dementia with Lewy bodies, vascular dementia and Parkinson's dementia.
See below for the local treatment pathways

Rivastigmine has been recommended as BLUE (with information sheet) for those patients who are stable and suitable for discharge from specialist care.

AMBER shared care  will apply for the patients that are not suitable for discharge and who will continue to receive follow up by SABPT

Note - the branded rivastigmine, Exelon, has been assigned a BLACK traffic light status and should not be prescribed